Acute exacerbation of interstitial lung disease after procedures

William H. Amundson; Emilian Racila; Tadashi Allen; H. Erhan Dincer; Rade Tomic; Maneesh Bhargava; David M. Perlman; Hyun Joo Kim

doi:10.1016/j.rmed.2019.02.012

Acute exacerbation of interstitial lung disease after procedures

William H. Amundson, Emilian Racila, Tadashi Allen, H. Erhan Dincer, Rade Tomic, Maneesh Bhargava, David M. Perlman, Hyun Joo Kim

Research output: Contribution to journal › Review article › peer-review

36 Scopus citations

Abstract

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Original language	English (US)
Pages (from-to)	30-37
Number of pages	8
Journal	Respiratory Medicine
Volume	150
DOIs	https://doi.org/10.1016/j.rmed.2019.02.012
State	Published - Apr 2019

Bibliographical note

Publisher Copyright:
© 2019 Elsevier Ltd

Keywords

AE-ILD
Acute exacerbation
Acute exacerbation of interstitial lung disease
Interstitial lung disease
Lung biopsy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.rmed.2019.02.012

OpenUrl availability

Full text

Cite this

@article{23fbdcd784e0423f92584202d34b0bd3,

title = "Acute exacerbation of interstitial lung disease after procedures",

abstract = "Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.",

keywords = "AE-ILD, Acute exacerbation, Acute exacerbation of interstitial lung disease, Interstitial lung disease, Lung biopsy",

author = "Amundson, {William H.} and Emilian Racila and Tadashi Allen and Dincer, {H. Erhan} and Rade Tomic and Maneesh Bhargava and Perlman, {David M.} and Kim, {Hyun Joo}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = apr,

doi = "10.1016/j.rmed.2019.02.012",

language = "English (US)",

volume = "150",

pages = "30--37",

journal = "Respiratory Medicine",

issn = "0954-6111",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Acute exacerbation of interstitial lung disease after procedures

AU - Amundson, William H.

AU - Racila, Emilian

AU - Allen, Tadashi

AU - Dincer, H. Erhan

AU - Tomic, Rade

AU - Bhargava, Maneesh

AU - Perlman, David M.

AU - Kim, Hyun Joo

PY - 2019/4

Y1 - 2019/4

N2 - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

AB - Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

KW - AE-ILD

KW - Acute exacerbation

KW - Acute exacerbation of interstitial lung disease

KW - Interstitial lung disease

KW - Lung biopsy

UR - http://www.scopus.com/inward/record.url?scp=85061673819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061673819&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2019.02.012

DO - 10.1016/j.rmed.2019.02.012

M3 - Review article

C2 - 30961948

AN - SCOPUS:85061673819

SN - 0954-6111

VL - 150

SP - 30

EP - 37

JO - Respiratory Medicine

JF - Respiratory Medicine

ER -

Acute exacerbation of interstitial lung disease after procedures

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this